1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Myelofibrosis (MF): new trials by email Literature Review of Myelofibrosis (MF) trials Research Report on Myelofibrosis (MF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis Luspatercept, Control - Luspatercept, Poor Erythroid Engraftment | Phase 2 / Phase 3 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 196 | 2026-05-01 | 2026-04-20 |
| Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis Placebo for Navitoclax, Ruxolitinib, Navitoclax - Myelofibrosis (MF) | Phase 3 | Completed | AbbVie | 252 | 2020-09-29 | 2026-03-23 |
| Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis Navitoclax, Ruxolitinib, Best Available Therapy (BAT) - Myelofibrosis (MF) | Phase 3 | Active not recruiting | AbbVie | 330 | 2020-08-31 | 2026-01-09 |
Primary Myelofibrosis (3) · Neoplasms (2) · Hematologic Neoplasms (1)
Bone Marrow Diseases (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Myeloproliferative Disorders (3) · Neoplasms (1) · Neoplasms by Site (1)
navitoclax (2) · ruxolitinib (2) · luspatercept (1)
AbbVie (2) · Nanfang Hospital, Southern Medical University (1)
Australia (2) · Austria (2) · Belgium (2) · Bulgaria (2) · Canada (2) · Croatia (2) · France (2) · Germany (2) · Greece (2) · Israel (2) · Italy (2) · Japan (2) · New Zealand (2) · Russia (2) · Serbia (2)
Qifa Liu (1)
PMID 20424252, PMID 28096091, PMID 29895954, PMID 34002031, PMID 37311468, PMID 42842696
2023 (1)